Clinical Trials Logo

Hemiparetic Cerebral Palsy clinical trials

View clinical trials related to Hemiparetic Cerebral Palsy.

Filter by:
  • None
  • Page 1

NCT ID: NCT06438666 Not yet recruiting - Clinical trials for Hemiparetic Cerebral Palsy

Effects Obtained at Manual Function After Applying Anodic Transcranial Direct Current Stimulation (tCDS) in Children With Spastic Hemiparetic Cerebral Palsy

PeditCDS
Start date: March 20, 2025
Phase: N/A
Study type: Interventional

Spastic Hemiparetic Cerebral Palsy (SHCP) uses to limit the manual function. Using anodic transcranial direct current stimulation, it is possible to activate certain cerebral areas depending on where the electrodes are. This study will use this kind of stimulation on the contralateral primary motor cortex of the affected upper limb and analyze the effects.

NCT ID: NCT05349136 Enrolling by invitation - Clinical trials for Hemiparetic Cerebral Palsy

Telerehabilitation-Based Action Observation Treatment in Children With Hemiparetic Cerebral Palsy

Start date: November 9, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effectiveness of action observation therapy applied using two different telerehabilitation techniques (synchronous and asynchronous) to children with hemiparetic cerebral palsy.

NCT ID: NCT03792789 Not yet recruiting - Clinical trials for Hemiparetic Cerebral Palsy

Evaluation of Repetitive Transcranial Magnetic Stimulation as an Adjunct to Modified Constraint Induced Movement Therapy in Improving Upper Limb Function in Children With Hemiparetic Cerebral Palsy Aged 5 - 18 Years

Start date: January 15, 2019
Phase: N/A
Study type: Interventional

The investigators aim to evaluate efficacy of TMS as an adjunct to CIMT, assess its safety and tolerability and study cortical excitability with help of TMS which are both rehabilitative therapies for hemiplegic cerebral palsy.

NCT ID: NCT00991692 Completed - Clinical trials for Hemiparetic Cerebral Palsy

A Multisite Trial of ACQUIREc Therapy

Start date: June 2008
Phase: N/A
Study type: Interventional

A multisite trial to testing different dosage levels of a systematic form of Pediatric Constraint-Induced (CI) Therapy called ACQUIREc Therapy. The high dosage treatment involved 6 hours of daily therapy services for 21 days. This was compared to a moderate dosage level of 3 hours of daily therapy services for 21 days. It was hypothesized that children receiving the higher therapy dosage would have greater and more clinically significant benefits from ACQUIREc Therapy but that both groups of children would benefit from the therapy services.